Browsed by
Tag: company

The New Home Company Reports Selected 2020 Third Quarter Preliminary Results

The New Home Company Reports Selected 2020 Third Quarter Preliminary Results

The New Home Company Inc. (NYSE: NWHM) today announced selected preliminary results for the 2020 third quarter. These estimated results are preliminary and unaudited.

Preliminary 2020 Third Quarter Financial Highlights (Estimated Results)

  • Net new orders of 251 as compared to 124 in the 2019 third quarter, a 102% increase

  • Monthly sales absorption of 3.5 per community as compared to 2.0 per community in the 2019 third quarter, a 75% increase

  • September net new orders of 99, a 106% increase compared to September 2019

  • Homes in backlog of 329 homes, representing $207.1 million in backlog value, as compared to 207 homes at the end of the 2019 third quarter, a 59% increase

  • Ending actively selling community count of 25, a 14% increase compared to the end of the 2019 third quarter

  • Homes sales revenue of $117.4 million as compared to $118.8 million for the 2019 third quarter

    • Deliveries of 157 as compared to 124 in the 2019 third quarter, a 27% increase

    • Average sales price of $748,000 as compared to $958,000 in the 2019 third quarter

  • Fee building revenues of $13.4 million as compared to $22.3 million for the 2019 third quarter

  • Cash and cash equivalents of $126.4 million as of September 30, 2020 as compared to $85.6 million as of June 30, 2020

  • Total debt, net of $290.3 million as compared to $327.4 million as of September 30, 2019

“The New Home Company continues to benefit from an incredibly strong housing market, as September’s order activity represented the highest monthly net order total in our company’s history driven by a monthly sales absorption rate of 4.0 per community,” said New Home Company CEO Leonard Miller. “Our preliminary results in the third quarter were also positively impacted by our ongoing shift to more affordable product, which helped push our monthly sales

Read the rest
AM Best Affirms Credit Ratings of Journey Insurance Company

AM Best Affirms Credit Ratings of Journey Insurance Company

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” of Journey Insurance Company (Journey) (St. Petersburg, FL). The outlook of these Credit Ratings (ratings) is stable.

The ratings reflect Journey’s balance sheet strength, which AM Best categorizes as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM).

Journey is majority owned by United Insurance Holdings Corp. (United) [NASDAQ: UIHC]. Journey was created in 2018 to take advantage of market opportunities within Florida, Texas and South Carolina, specifically regarding property coverage. The company’s balance sheet strength assessment is influenced by the infusion of significant capital intended to support its growth as it relates to underwriting, credit and investment risks. United provides strategic administration and operational support as it pertains to underwriting, ERM, claims, leadership and other functions. The ratings and outlooks consider the substantial support and proven track record of United.

Maintaining the ratings and outlooks at current levels will depend on successful execution of development plans as communicated by management, efficient use of strategic business partnerships, and effective management of Journey’s catastrophe exposure, which will grow as the company expands. Initial operations were delayed somewhat, as management made the strategic decision to pivot from the use of legacy systems to newer platforms; however, growth in the current period is in line with expectations.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to

Read the rest
Polish e-commerce company Allegro lights up Europe’s IPO market

Polish e-commerce company Allegro lights up Europe’s IPO market

WARSAW/GDANSK, Poland (Reuters) – Shares in Polish e-commerce group Allegro leapt more than 60% on their debut on Monday, giving the company a market value of almost $19 billion in Europe’s biggest initial public offering (IPO) so far this year.

Allegro logo is seen on a smartphone in front of a displayed stock graph in this illustration taken October 12, 2020. REUTERS/Dado Ruvic/Illustration

Founded more than 20 years ago as a home-grown rival to eBay, Allegro is central Europe’s most recognised e-commerce brand and its website is attracting 20 million visitors a month as consumers go online during the COVID-19 pandemic.

Allegro’s strong start mirrored the performance of some recent IPOs in the United States where shares have shot up as investors showed they were willing to pay for companies with potential for growth.

Last month, British e-commerce firm The Hut Group made the biggest debut on the London Stock Exchange in seven years and Allegro’s successful launch was a further sign the European IPO market is picking up.

However, investor appetite seems to be reserved for tech and growth companies – sectors that corporate Europe is light on compared to the United States, where a number of blockbuster tech IPOs have launched this year.

“The recent pandemic highlighted the value of e-commerce for a consumer, and accelerated e-commerce penetration,” said Ivan Kim, an analyst at Xtellus Capital. “Allegro is a well-established marketplace … and is already quite profitable.”

Shares in Allegro closed the day at 70 zlotys, up 63% from their IPO price of 43 zlotys, which was at the upper end of the guidance range.

Allegro immediately became the most valuable company on the Warsaw bourse, which said the company would replace Commerzbank’s mBank in its index of the 20 biggest companies WIG20

Read the rest
AM Best Affirms Credit Ratings of Members of Standard Insurance Group and Pacific Guardian Life Insurance Company, Limited

AM Best Affirms Credit Ratings of Members of Standard Insurance Group and Pacific Guardian Life Insurance Company, Limited

OLDWICK, N.J.–(BUSINESS WIRE)–Oct 9, 2020–

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” of Standard Insurance Company (Portland, OR) and its affiliate, The Standard Life Insurance Company of New York (White Plains, NY), together referred to as the Standard Insurance Group (The Standard). Additionally, AM Best has affirmed the Long-Term ICR of “bbb+” and the Long-Term Issue Credit Rating (Long-Term IR) of “bbb+” on the outstanding $250 million 5% senior unsecured notes, due 2022, of StanCorp Financial Group, Inc. (StanCorp Financial) (Portland, OR), the intermediate holding company of The Standard.

Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of “a” of Pacific Guardian Life Insurance Company, Limited (Pacific Guardian) (Honolulu, HI). The outlook of these Credit Ratings (ratings) is stable. The Standard and Pacific Guardian are the U.S. insurance subsidiaries of Meiji Yasuda Life Insurance Company (Meiji Yasuda).

The ratings of The Standard reflect its balance sheet strength, which AM Best categorizes as strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management (ERM).

The Standard’s risk-adjusted capital has shown incremental increases over the past two years based on favorable operating results. Dividends to the parent have been lower than historical levels, which has contributed to the capital appreciation. Approximately one-third of The Standard’s invested assets are held in commercial mortgage loans with a concentration of loans on the West Coast. The portfolio is currently performing well as The Standard is the direct underwriter of the loans and has strong underwriting capabilities based on its long history as a loan originator. However, commercial mortgage loan performance overall is under pressure due to the economic impact of the COVID-19 pandemic, especially in retail and hospitality

Read the rest
Vetphage Pharmaceuticals rebranded with its mother company brand Proteon Pharmaceuticals

Vetphage Pharmaceuticals rebranded with its mother company brand Proteon Pharmaceuticals

Vetphage Pharmaceuticals, a company operating in the animal health industry, known for their support to Poultry farmers and Aquaculture, has been successfully rebranded to Proteon Pharmaceuticals India Pvt. Ltd. Being established in India in 2017, the Vetphage has proven to be a reliable partner for Proteon Pharmaceuticals S.A, its mother company headquartered in Poland, Europe. Proteon is a leader in bacteriophage (phage) technology for livestock farming. Proteon’s products modulate the microbiome, enhancing sustainability and improving performance on the farm. The company currently operates worldwide with footprints in Europe, APAC and Middle East.

Vetphage has shown a promising potential in the first few years of its operations. Having recorded 175% revenue increase in the first 6 months of 2020 despite the general countrywide lockdown, the company is forecasting more than 200% growth in H2 of 2020 compared to H1. “Since poultry producers are switching over to safer and efficient feed additives, we expect to see substantial growth in our sales volume and market share. A bulk of the growth is likely to accrue from the South and West markets, with sizable contributions from the North, Central and Eastern Indian regions. We expect 40% growth in revenue in the Southern region comprising AP, Karnataka, TN, Kerala, Telangana, and a 20% growth in the Western region, comprising Maharashtra and Gujarat ” said Dr Ramdas Kambale, Director of Proteon Pharmaceuticals India.

Indian Poultry market is currently valued at Rs. 10,000 crores and growing annually with a compounded growth rate of 10 percent, which is among the highest in the world.

“Proteon strives to capture the Indian market under one global brand. It’ll bring savings that we will translate to even better support our customers” said Mr. Nipun Gupta, Chief Commercial Officer at Proteon Pharmaceuticals S.A. The new approach of poultry integrators is fostering growth

Read the rest